Mok, T. S., Wu, Y. L., Thongprasert, S., Yang, C. H., Chu, D. T., Saijo, N., . . . Fukuoka, M. (2018). Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma.
Chicago Style CitationMok, Tony S., et al. Gefitinib or Carboplatin-paclitaxel in Pulmonary Adenocarcinoma. 2018.
MLA引文Mok, Tony S., et al. Gefitinib or Carboplatin-paclitaxel in Pulmonary Adenocarcinoma. 2018.
警告：這些引文格式不一定是100％准確.